論文・総説 - 稲澤　譲治

481. Nishi M, Inazawa J, Inoue K, Nakagawa H, Taniwaki M, Misawa S, Oikawa S, Nakazato H, Abe T. Regional chromosomal assignment of carcinoembryonic antigen gene (CEA) to chromosome 19 at band q13.2. Cancer Genet Cytogenet. 1991.07; 54 (1): 77-81. ( PubMed )

482. Sugimoto T, Ueyama H, Hosoi H, Inazawa J, Kato T, Kemshead JT, Reynolds CP, Gown AM, Mine H, Sawada T. Alpha-smooth-muscle actin and desmin expressions in human neuroblastoma cell lines. Int J Cancer. 1991.05; 48 (2): 277-283. ( PubMed )

483. Kuroda H, Sugimoto T, Ueda K, Tsuchida S, Horii Y, Inazawa J, Sato K, Sawada T. Different drug sensitivity in two neuroblastoma cell lines established from the same patient before and after chemotherapy. Int J Cancer. 1991.03; 47 (5): 732-737. ( PubMed )

484. Uike N, Inazawa J, Nishigaki H, Takahira H, Katsuno M, Hashimoto M, Kozuru M. Missing Y chromosome in Ph1-negative chronic myeloid leukemia with bcr rearrangement. Evidence for a bcr-abl recombination on chromosome 22 by in situ hybridization. Acta Haematol. 1991; 85 (1): 51-55. ( PubMed )

485. Tanaka S, Nishigaki H, Misawa S, Taniwaki M, Nakagawa H, Yashige H, Horiike S, Kashima K, Inazawa J, Sonoda Y, et al.. Lack of involvement of the G-CSF gene by chromosomal translocation t(15;17) in acute promyelocytic leukemia. Leukemia. 1990.07; 4 (7): 494-496. ( PubMed )

486. Hayashi Y, Sugimoto T, Horii Y, Hosoi H, Inazawa J, Kemshead JT, Inaba T, Hanada R, Yamamoto K, Gown AM, et al.. Characterization of an embryonal rhabdomyosarcoma cell line showing amplification and over-expression of the N-myc oncogene. Int J Cancer. 1990.04; 45 (4): 705-711. ( PubMed )

487. Horiike S, Taniwaki M, Misawa S, Nishigaki H, Okuda T, Yokota S, Kashima K, Inazawa J, Abe T. The unbalanced 1;7 translocation in de novo myelodysplastic syndrome and its clinical implication. Cancer. 1990.03; 65 (6): 1350-1354. ( PubMed )

488. Inazawa J, Nakagawa H, Misawa S, Abe T, Minoshima S, Fukuyama R, Maki M, Murachi T, Hatanaka M, Shimizu N. Assignment of the human calpastatin gene (CAST) to chromosome 5 at region q14----q22. Cytogenet Cell Genet. 1990; 54 (3-4): 156-158. ( PubMed )

489. Taniwaki M, Nakagawa H, Tanaka S, Nishigaki H, Horiike S, Nishida K, Tsuda S, Misawa S, Inazawa J, Abe T. Long arm deletion of chromosome 7 unrelated to original karyotype in recurrent t(8;21) acute myeloblastic leukemia. Acta Haematol. 1990; 83 (3): 159-162. ( PubMed )

490. Nishigaki H, Inazawa J, Misawa S, Nishida K, Okuda T, Horiike S, Tsuda S, Taniwaki M, Abe T. Distribution of breakpoint within the breakpoint cluster region (bcr) in chronic myelogenous leukemia with a complex Philadelphia chromosome translocation. Am J Hematol. 1989.11; 32 (3): 194-199. ( PubMed )

491. Tsuda S, Tanaka S, Nakagawa H, Nishigaki H, Okuda T, Horiike S, Taniwaki M, Misawa S, Inazawa J, Abe T, et al.. [Clinical evaluation of a combination therapy with aztreonam and clindamycin for severe infections in leukemia and related disorders]. Jpn J Antibiot. 1989.09; 42 (9): 1926-1937. ( PubMed )

492. Inazawa J, Nishigaki H, Takahira H, Nishimura J, Horiike S, Taniwaki M, Misawa S, Abe T. Rejoining between 9q+ and Philadelphia chromosomes results in normal-looking chromosomes 9 and 22 in Ph1-negative chronic myelocytic leukemia. Hum Genet. 1989.09; 83 (2): 115-118. ( PubMed )

493. Hino T, Sugimoto T, Matsumura T, Horii Y, Inazawa J, Sawada T. Diverse responses to retinoid in morphological differentiation, tumorigenesis and N-myc expression in human neuroblastoma sublines. Int J Cancer. 1989.08; 44 (2): 286-291. ( PubMed )

494. Nishida K, Yashige H, Maekawa T, Fujii H, Taniwaki M, Horiike S, Misawa S, Inazawa J, Abe T. Chromosome rearrangement, t(6;14) (p21.1;q32.3), in multiple myeloma. Br J Haematol. 1989.02; 71 (2): 295-296. ( PubMed )

495. Inazawa J, Abe T, Inoue K, Nishigaki H, Horiike S, Taniwaki M, Misawa S, Takino T. Simultaneous existence of double minute chromosomes and a homogeneously staining region in a retinoblastoma cell line (Y79) and amplification of N-myc at HSR. Cancer Genet Cytogenet. 1989.01; 37 (1): 133-137. ( PubMed )

496. Inazawa J, Inoue K, Nishigaki H, Tsuda S, Taniwaki M, Misawa S, Abe T. Assignment of the human myeloperoxidase gene (MPO) to bands q21.3----q23 of chromosome 17. Cytogenet Cell Genet. 1989; 50 (2-3): 135-136. ( PubMed )

497. Inazawa J, Abe T, Inoue K, Misawa S, Oikawa S, Nakazato H, Yoshida MC. Regional assignment of nonspecific cross-reacting antigen (NCA) of the CEA gene family to chromosome 19 at band q13.2. Cytogenet Cell Genet. 1989; 52 (1-2): 28-31. ( PubMed )

498. Tsuda S, Nishigaki H, Okuda T, Horiike S, Yokota S, Yashige H, Taniwaki M, Misawa S, Takino T, Inazawa J, et al.. [Clinical evaluation of a combination treatment with cefmenoxime and cefsulodin of severe infections in leukemia and related disorders]. Jpn J Antibiot. 1988.05; 41 (5): 577-587. ( PubMed )

499. Abe T, Yashige H, Inazawa J, Yokota S, Tsuda S, Taniwaki M, Takeda S, Misawa S, Takino T. The use of diamox in the sequential methotrexate-5-fluorouracil therapy of advanced gastrointestinal cancer. Eur J Cancer Clin Oncol. 1988.04; 24 (4): 799-800. ( PubMed )

500. Taniwaki M, Horiike S, Inazawa J, Nishida K, Misawa S, Takino T, Abe T. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis. Jpn J Clin Oncol. 1987.06; 17 (2): 141-150. ( PubMed )